Publications by authors named "Hugh Watson"

Claim this Profile
R
Re: 'Learning from post COVID-19 condition for epidemic preparedness' by Górska et al.
Hugh R Watson

Clin Microbiol Infect· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global ultrasound synovitis scores reflect symptom severity and patient outcomes in chronic chikungunya disease.
Hugh Watson, Juana Del Valle-Mendoza, Miguel Angel Aguilar-Luis, Ronald Aquino-Ortega, Wilmer Silva-Caso

Rheumatology (Oxford)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Viral Kinetics During Acute Chikungunya Virus Infection: Insights Into Potential Role of Monoclonal Antibodies in Viral Clearance and Prophylaxis Using Mathematical Modeling.
Tey Putita Ou, Sopheak Sorn, Kunthy Nguon, Saraden In, Sreymom Ken, Hugh Watson

J Med Virol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genotypic diversity and molecular characterization of DENV-2 in a Peruvian endemic region from 2016 to 2022: displacement of American/Asian genotype.
Yordi Tarazona-Castro, Miguel Angel Aguilar-Luis, Wilmer Silva-Caso, Hugh Watson, Victor Zavaleta-Gavidia

Front Microbiol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simvastatin and Rifaximin in Decompensated Cirrhosis: A Randomized Clinical Trial.
Elisa Pose, César Jiménez, Giacomo Zaccherini, Daniela Campion, Salvatore Piano, Hugh Watson

JAMA· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delta in Denmark: prevalence of hepatitis delta virus infection.
Hugh Watson, Peter Jepsen, Hendrik Vilstrup, Henrik Krarup

Infect Dis (Lond)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The CIRrhotic Ascites Severity (CIRAS) model predicts hepatic hydrothorax at all stages of ascites.
Rasmus Hvidbjerg Gantzel, Thomas Deleuran, Hendrik Vilstrup, Hugh Watson, Peter Jepsen

Clin Res Hepatol Gastroenterol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized clinical trial on safety of the natriuretic peptide ularitide as treatment of refractory cirrhotic ascites.
Rasmus H Gantzel, Emilie E Møller, Niels K Aagaard, Hugh Watson, Peter Jepsen

Hepatol Commun· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a Chikungunya Arthritis Disease Activity Score (CHIK-DAS) Based on a Prospective Cohort Study.
Aileen Y Chang, Samuel Simmens, Hugh Watson, Richard L Amdur, André Siqueira

J Cell Immunol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysis.
Adrià Juanola, Ann Thu Ma, Koos de Wit, Kohilan Gananandan, Olivier Roux, Hugh Watson

Gut· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Chikungunya virus: A reemerging cause of acute febrile illness in the high jungle of northern Peru.
Miguel Angel Aguilar-Luis, Hugh Watson, Yordi Tarazona-Castro, Lucinda Troyes-Rivera, Felipe Cabellos-Altamirano

PLoS Negl Trop Dis· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-Selective Beta-Blockers and Risk of Sepsis in Patients with Cirrhosis and Ascites: Results from a Large Observational Study.
Morten Daniel Jensen, Hugh Watson, Hendrik Vilstrup, Peter Jepsen

Clin Epidemiol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of the Cirrhotic Ascites Severity model-A patient-reported outcome-based model to predict 1-year mortality.
Rasmus Hvidbjerg Gantzel, Niels Kristian Aagaard, Hendrik Vilstrup, Hugh Watson, Henning Grønbæk

Hepatol Commun· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Household clustering supports a novel chemoprophylaxis trial design for a mosquito-borne viral disease.
Hugh R Watson, Veasna Duong, Sowath Ly, Marie Mandron, André M Siqueira

Int J Infect Dis· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of Health-Related Quality of Life in Chronic Chikungunya Disease in Guadeloupe.
Fabrice Simon, Rémi Bossy, Denise Federico, Julien Dezaunay, Anne-Laurence Demoux, Hugh Watson

Pathogens· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Factors for Hepatic Hydrothorax in Cirrhosis Patients with Ascites - A Clinical Cohort Study.
Thomas Deleuran, Hugh Watson, Hendrik Vilstrup, Peter Jepsen

Dig Dis Sci· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spontaneous bacterial peritonitis has no effect on the long-term prognosis of cirrhosis patients with ascites.
Thomas Deleuran, Hugh Watson, Hendrik Vilstrup, Peter Jepsen

Ann Hepatol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic and prophylactic treatment with a virus-specific antibody is highly effective in rodent models of Chikungunya infection and disease.
Justin G Julander, Nicole Anderson, Nicole Haese, Takeshi Andoh, Daniel N Streblow, Hugh Watson

Antiviral Res· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis.
Elisa Pose, Elsa Solà, Juan J Lozano, Adrià Juanola, Julia Sidorova, Hugh Watson

Hepatol Commun· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects and safety of natriuretic peptides as treatment of cirrhotic ascites: A systematic review and meta-analysis.
Rasmus Hvidbjerg Gantzel, Mikkel Breinholt Kjær, Peter Jepsen, Niels Kristian Aagaard, Hugh Watson

World J Hepatol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arthralgia resolution rate following chikungunya virus infection.
Megan O'Driscoll, Henrik Salje, Aileen Y Chang, Hugh Watson

Int J Infect Dis· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ularitide as treatment of refractory ascites in cirrhosis- a study protocol for a randomised trial.
Rasmus Hvidbjerg Gantzel, Markus Meyer, Stefan Mazgareanu, Niels Kristian Aagaard, Peter Jepsen, Hugh Watson

Dan Med J· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tender and swollen joint counts are poorly associated with disability in chikungunya arthritis compared to rheumatoid arthritis.
Hugh Watson, Ramão Luciano Nogueira-Hayd, Maony Rodrigues-Moreno, Felipe Naveca, Giulia Calusi

Sci Rep· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What chikungunya teaches us about COVID-19.
Fabrice Simon, Hugh Watson, Jean-Baptiste Meynard, Vincent Pommier de Santi, Jean-Nicolas Tournier

Lancet Infect Dis· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endpoints and design of clinical trials in patients with decompensated cirrhosis: Position paper of the LiverHope Consortium.
Elsa Solà, Elisa Pose, Daniela Campion, Salvatore Piano, Olivier Roux, Hugh Watson

J Hepatol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis